Mechanisms and implications of age-associated impaired innate interferon secretion by dendritic cells: A mini-review

Gerontology

Volumn 59, Issue 5, 2013, Pages 421-426

  Agrawal, Anshu ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Aging; Dendritic cells; Type I interferon; Type III interferon

Indexed keywords

INTERFERON; INTERFERON REGULATORY FACTOR 7; INTERLEUKIN 10; INTERLEUKIN 12P40; INTERLEUKIN 22; INTERLEUKIN 26; INTERLEUKIN 28A; INTERLEUKIN 29; INTERLEUKIN 6; MYELOID DIFFERENTIATION FACTOR 88; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 9; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6; INTERLEUKIN 28B;

ADAPTIVE IMMUNITY; AGING; AUTOPHOSPHORYLATION; CYTOKINE RELEASE; DENDRITIC CELL; HUMAN; IMMUNE RESPONSE; IMMUNOLOGICAL MEMORY; INFECTION; MYELOID DENDRITIC CELL; NONHUMAN; PLASMACYTOID DENDRITIC CELL; PRIORITY JOURNAL; REVIEW; DISEASE PREDISPOSITION; INNATE IMMUNITY; RESPIRATORY TRACT MUCOSA;

AGING; ANIMALS; DENDRITIC CELLS; HUMANS; IMMUNITY, INNATE; INTERFERON TYPE I; INTERFERONS; INTERLEUKINS; MODELS, IMMUNOLOGICAL;

EID: 84883454662     PISSN: 0304324X     EISSN: 14230003     Source Type: Journal    
DOI: 10.1159/000350536     Document Type: Review

References (30)

1. Elliot AJ, Fleming DM: Influenza and respiratory syncytial virus in the elderly. Expert Rev Vaccines 2008; 7: 249-258.
2. Garcia-Sastre A, Biron CA: Type 1 interferons and the virus-host relationship: A lesson in detente. Science 2006; 312: 879-882.
3. Gilliet M, Cao W, Liu YJ: Plasmacytoid dendritic cells: Sensing nucleic acids in viral infection and autoimmune diseases. Nat Rev Immunol 2008; 8: 594-606.
4. Honda K, Yanai H, Negishi H, Asagiri M, Sato M, Mizutani T, Shimada N, Ohba Y, Takaoka A, Yoshida N, Taniguchi T: IRF-7 is the master regulator of type-I interferon-dependent immune responses. Nature 2005; 434: 772- 777.
5. Shodell M, Siegal FP: Circulating, interferonproducing plasmacytoid dendritic cells decline during human ageing. Scand J Immunol 2002; 56: 518-521.
6. Perez-Cabezas B, Naranjo-Gomez M, Fernandez MA, Grifols JR, Pujol-Borrell R, Borras FE: Reduced numbers of plasmacytoid dendritic cells in aged blood donors. Exp Gerontol 2007; 42: 1033-1038.
7. Jing Y, Shaheen E, Drake RR, Chen N, Gravenstein S, Deng Y: Aging is associated with a numerical and functional decline in plasmacytoid dendritic cells, whereas myeloid dendritic cells are relatively unaltered in human peripheral blood. Hum Immunol 2009; 70: 777-784.
8. Canaday DH, Amponsah NA, Jones L, Tisch DJ, Hornick TR, Ramachandra L: Influenzainduced production of interferon-alpha is defective in geriatric individuals. J Clin Immunol 2010; 30: 373-383.
9. Agrawal A, Agrawal S, Cao JN, Su H, Osann K, Gupta S: Altered innate immune functioning of dendritic cells in elderly humans: A role of phosphoinositide 3-kinase-signaling pathway. J Immunol 2007; 178: 6912-6922.
10. Sridharan A, Esposo M, Kaushal K, Tay J, Osann K, Agrawal S, Gupta S, Agrawal A: Age-associated impaired plasmacytoid dendritic cell functions lead to decreased CD4 and CD8 T cell immunity. Age (Dordr) 2011; 33: 363-376.
11. Della Bella S, Bierti L, Presicce P, Arienti R, Valenti M, Saresella M, Vergani C, Villa ML: Peripheral blood dendritic cells and monocytes are differently regulated in the elderly. Clin Immunol 2007; 122: 220-228.
12. Panda A, Qian F, Mohanty S, van Duin D, Newman FK, Zhang L, Chen S, Towle V, Belshe RB, Fikrig E, Allore HG, Montgomery RR, Shaw AC: Age-associated decrease in TLR function in primary human dendritic cells predicts influenza vaccine response. J Immunol 2010; 184: 2518-2527.
13. Cao W, Manicassamy S, Tang H, Kasturi SP, Pirani A, Murthy N, Pulendran B: Toll-like receptor-mediated induction of type I interferon in plasmacytoid dendritic cells requires the rapamycin-sensitive PI(3)K-mTORp70s6K pathway. Nat Immunol 2008; 9: 1157- 1164.
14. Stout-Delgado HW, Yang X, Walker WE, Tesar BM, Goldstein DR: Aging impairs IFN regulatory factor 7 up-regulation in plasmacytoid dendritic cells during TLR9 activation. J Immunol 2008; 181: 6747-6756.
15. Qian F, Wang X, Zhang L, Lin A, Zhao H, Fikrig E, Montgomery RR: Impaired interferon signaling in dendritic cells from older donors infected in vitro with West Nile virus. J Infect Dis 2011; 203: 1415-1424.
16. Uno K, Yagi K, Yoshimori M, Tanigawa M, Yoshikawa T, Fujita S: IFN production ability and healthy ageing: Mixed model analysis of a year longitudinal study in Japan. BMJ Open 2013; 3.
17. Agrawal A, Tay J, Ton S, Agrawal S, Gupta S: Increased reactivity of dendritic cells from aged subjects to self-antigen, the human DNA. J Immunol 2009; 182: 1138-1145.
18. Prakash S, Agrawal S, Cao JN, Gupta S, Agrawal A: Impaired secretion of interferons by dendritic cells from aged subjects to influenza: Role of histone modifications. Age (Dordr) 2012, epub ahead of print
19. Gonzalez-Navajas JM, Lee J, David M, Raz E: Immunomodulatory functions of type I interferons. Nat Rev Immunol 2012; 12: 125-135.
20. Kolumam GA, Thomas S, Thompson LJ, Sprent J, Murali-Krishna K: Type I interferons act directly on CD8 T cells to allow clonal expansion and memory formation in response to viral infection. J Exp Med 2005; 202: 637-650.
21. Heitger A: Regulation of expression and function of IDO in human dendritic cells. Curr Med Chem 2011; 18: 2222-2233.
22. Hoshi M, Saito K, Hara A, Taguchi A, Ohtaki H, Tanaka R, Fujigaki H, Osawa Y, Takemura M, Matsunami H, Ito H, Seishima M: The absence of IDO upregulates type I IFN production, resulting in suppression of viral replication in the retrovirus-infected mouse. J Immunol 2010; 185: 3305-3312.
23. Scheler M, Wenzel J, Tuting T, Takikawa O, Bieber T, von Bubnoff D: Indoleamine 2,3-dioxygenase (IDO). The antagonist of type I interferon- driven skin inflammation? Am J Pathol 2007; 171: 1936-1943.
24. Mozzillo N, Ascierto P: Reduction of circulating regulatory T cells by intravenous highdose interferon alfa-2b treatment in melanoma patients. Clin Exp Metastasis 2012; 29: 801-805.
25. Hoshi M, Matsumoto K, Ito H, Ohtaki H, Arioka Y, Osawa Y, Yamamoto Y, Matsunami H, Hara A, Seishima M, Saito K: L -Tryptophan- kynurenine pathway metabolites regulate type I IFNs of acute viral myocarditis in mice. J Immunol 2012; 188: 3980-3987.
26. Pertovaara M, Raitala A, Lehtimaki T, Karhunen PJ, Oja SS, Jylha M, Hervonen A, Hurme M: Indoleamine 2,3-dioxygenase activity in nonagenarians is markedly increased and predicts mortality. Mech Age Dev 2006; 127: 497-499.
27. Pawelec G, Barnett Y, Forsey R, Frasca D, Globerson A, McLeod J, Caruso C, Franceschi C, Fulop T, Gupta S, Mariani E, Mocchegiani E, Solana R: T cells and aging, January 2002 update. Front Biosci 2002; 7:d1056-d1183.
28. Zhou Z, Hamming OJ, Ank N, Paludan SR, Nielsen AL, Hartmann R: Type III interferon (IFN) induces a type I IFN-like response in a restricted subset of cells through signaling pathways involving both the Jak-STAT pathway and the mitogen-activated protein kinases. J Virol 2007; 81: 7749-7758.
29. Ank N, Iversen MB, Bartholdy C, Staeheli P, Hartmann R, Jensen UB, Dagnaes-Hansen F, Thomsen AR, Chen Z, Haugen H, Klucher K, Paludan SR: An important role for type III interferon (IFN-lambda/IL-28) in TLR-induced antiviral activity. J Immunol 2008; 180: 2474-2485.
30. Koltsida O, Hausding M, Stavropoulos A, Koch S, Tzelepis G, Ubel C, Kotenko SV, Sideras P, Lehr HA, Tepe M, Klucher KM, Doyle SE, Neurath MF, Finotto S, Andreakos E: IL-28a (IFN-lambda2) modulates lung DC function to promote TH1 immune skewing and suppress allergic airway disease. EMBO Mol Med 2011; 3: 348-361.